PE20090565A1 - Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- PE20090565A1 PE20090565A1 PE2008001286A PE2008001286A PE20090565A1 PE 20090565 A1 PE20090565 A1 PE 20090565A1 PE 2008001286 A PE2008001286 A PE 2008001286A PE 2008001286 A PE2008001286 A PE 2008001286A PE 20090565 A1 PE20090565 A1 PE 20090565A1
- Authority
- PE
- Peru
- Prior art keywords
- pirrolo
- heteroaryl
- monociclic
- fluorobenzyl
- imidazo
- Prior art date
Links
- 150000003857 carboxamides Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 208000025865 Ulcer Diseases 0.000 abstract 2
- FIULGFJIHJJXMT-UHFFFAOYSA-N [C]1[N]C=CC=C1 Chemical class [C]1[N]C=CC=C1 FIULGFJIHJJXMT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 231100000397 ulcer Toxicity 0.000 abstract 2
- 208000004998 Abdominal Pain Diseases 0.000 abstract 1
- 208000000187 Abnormal Reflex Diseases 0.000 abstract 1
- 208000002881 Colic Diseases 0.000 abstract 1
- -1 INDOLYL Chemical class 0.000 abstract 1
- 102000003566 TRPV1 Human genes 0.000 abstract 1
- 101150016206 Trpv1 gene Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000003146 cystitis Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 206010020745 hyperreflexia Diseases 0.000 abstract 1
- 230000035859 hyperreflexia Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 230000003349 osteoarthritic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
REFERIDA A COMPUESTOS DERIVADOS DE N-HETEROARIL-CARBOXAMIDAS TRICICLICAS DE FORMULA (I) DONDE A CON EL ENLACE Z2-Z3 DEL BICICLO ES CICLOALQUILO(C4-C7), HETEROARILO MONOCICLICO O HETEROCICLO MONOCICLICO DE 4 A 7 MIEMBROS, INCLUIDOS LOS ATOMOS Z2 Y Z3; Z2, Z3, Z4 Y Z9 SON CADA UNO N O C; Z1, Z5, Z6, Z7 Y Z8 SON CADA UNO N, C O C-R2, DONDE R2 ES H, HALOGENO, ALQUILO(C1-C6), FLUOROALCOXI(C1-C6), ENTRE OTROS; W ES O O S; P ES INDOLILO, PIRROLO[2,3-c]PIRIDINILO, PIRROLO[3,2-b]PIRIDINILO, ENTRE OTROS; R3 Y R3' SON CADA UNO H, HALOGENO, ALQUILO(C1-C6), CICLOALQUILO(C3-C7), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-(2.3-DIHIDRO-1H-PIRROLO[1'.2':1.2]IMIDAZO[5.4-b]PIRIDIN-6-IL)-5-FLUORO-1-(3-FLUOROBENCIL)-1H-INDOL-2-CARBOXAMIDA, N-(3-ACETOXI-2.3-DIHIDRO-1H-PIRROLO[1'.2':1.2]IMIDAZO[5.4-b]PIRIDIN-6-IL)-5-FLUORO-1-(3-FLUOROBENCIL)-1H-INDOL-2-CARBOXAMIDA, N-(2.3-DIHIDRO-3-OXO-1H-PIRROLO[1'.2':1.2]IMIDAZO[5.4-b]PIRIDIN-6-IL)-5-FLUORO-1-(3-FLUOROBENCIL)-1H-INDOL-2-CARBOXAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DE LOS RECEPTORES DE TIPO TRPV1 SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR OSTEOARTRITICO, NEUROPATICO, DIABETES, HIPERREFLEXIA VESICAL, CISTITIS, COLICO NEFRITICO, ULCERA DE ESTOMAGO, ENFERMEDAD DE CROHN, ASMA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705677A FR2919610B1 (fr) | 2007-08-02 | 2007-08-02 | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090565A1 true PE20090565A1 (es) | 2009-06-01 |
Family
ID=39185736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001286A PE20090565A1 (es) | 2007-08-02 | 2008-07-31 | Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeutica |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8153796B2 (es) |
| EP (1) | EP2185558B1 (es) |
| JP (1) | JP5259713B2 (es) |
| KR (1) | KR20100041804A (es) |
| CN (1) | CN101772499B (es) |
| AR (1) | AR067754A1 (es) |
| AU (1) | AU2008313601B2 (es) |
| BR (1) | BRPI0814756A2 (es) |
| CA (1) | CA2694994C (es) |
| CL (1) | CL2008002289A1 (es) |
| CO (1) | CO6251362A2 (es) |
| EA (1) | EA017808B1 (es) |
| FR (1) | FR2919610B1 (es) |
| MA (1) | MA31687B1 (es) |
| MX (1) | MX2010001238A (es) |
| MY (1) | MY150428A (es) |
| NZ (1) | NZ582970A (es) |
| PA (1) | PA8790901A1 (es) |
| PE (1) | PE20090565A1 (es) |
| SG (1) | SG183080A1 (es) |
| TW (1) | TWI366566B (es) |
| UY (1) | UY31264A1 (es) |
| WO (1) | WO2009050348A1 (es) |
| ZA (1) | ZA201000745B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2980159A1 (en) * | 2015-03-18 | 2016-09-22 | Bristol-Myers Squibb Company | Substituted tricyclic heterocyclic compounds |
| JP6778251B2 (ja) | 2015-07-09 | 2020-10-28 | ビスタデルテク・リミテッド・ライアビリティ・カンパニーＶｉｓｔａｄｅｌｔｅｋ， Ｌｌｃ | 弁における制御板 |
| AU2016315648B2 (en) | 2015-08-28 | 2021-04-01 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| WO2022111473A1 (en) * | 2020-11-26 | 2022-06-02 | Bioardis Llc | Compounds as mrgprx2 antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0156327B1 (ko) * | 1995-07-12 | 1998-11-16 | 김종인 | 벤즈 또는 피리도이미다졸 유도체 |
| US6313242B1 (en) * | 1996-05-20 | 2001-11-06 | Fina Technology, Inc. | Stereorigid bis-fluorenyl metallocenes |
| US5708187A (en) * | 1996-06-27 | 1998-01-13 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists |
| US7531558B2 (en) * | 2003-02-14 | 2009-05-12 | Glaxo Group Limited | Carboxamide derivatives |
| WO2004108133A2 (en) * | 2003-06-05 | 2004-12-16 | Vertex Pharmaceuticals Incorporated | Modulators of vr1 receptor |
| GB0319151D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
| FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2897061B1 (fr) * | 2006-02-03 | 2010-09-03 | Sanofi Aventis | Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique. |
-
2007
- 2007-08-02 FR FR0705677A patent/FR2919610B1/fr active Active
-
2008
- 2008-07-29 PA PA20088790901A patent/PA8790901A1/es unknown
- 2008-07-30 TW TW097128801A patent/TWI366566B/zh not_active IP Right Cessation
- 2008-07-31 JP JP2010518710A patent/JP5259713B2/ja not_active Expired - Fee Related
- 2008-07-31 MX MX2010001238A patent/MX2010001238A/es active IP Right Grant
- 2008-07-31 PE PE2008001286A patent/PE20090565A1/es not_active Application Discontinuation
- 2008-07-31 SG SG2012055265A patent/SG183080A1/en unknown
- 2008-07-31 CA CA2694994A patent/CA2694994C/fr not_active Expired - Fee Related
- 2008-07-31 WO PCT/FR2008/001141 patent/WO2009050348A1/fr not_active Ceased
- 2008-07-31 NZ NZ582970A patent/NZ582970A/en not_active IP Right Cessation
- 2008-07-31 BR BRPI0814756A patent/BRPI0814756A2/pt not_active IP Right Cessation
- 2008-07-31 AR ARP080103318A patent/AR067754A1/es not_active Application Discontinuation
- 2008-07-31 EP EP08839139.6A patent/EP2185558B1/fr active Active
- 2008-07-31 EA EA201070217A patent/EA017808B1/ru not_active IP Right Cessation
- 2008-07-31 KR KR1020107002302A patent/KR20100041804A/ko not_active Ceased
- 2008-07-31 CN CN2008801014470A patent/CN101772499B/zh not_active Expired - Fee Related
- 2008-07-31 MY MYPI20100448 patent/MY150428A/en unknown
- 2008-07-31 AU AU2008313601A patent/AU2008313601B2/en not_active Ceased
- 2008-08-01 CL CL2008002289A patent/CL2008002289A1/es unknown
- 2008-08-01 UY UY31264A patent/UY31264A1/es not_active Application Discontinuation
-
2010
- 2010-01-29 US US12/696,149 patent/US8153796B2/en not_active Expired - Fee Related
- 2010-02-01 CO CO10010102A patent/CO6251362A2/es active IP Right Grant
- 2010-02-01 ZA ZA2010/00745A patent/ZA201000745B/en unknown
- 2010-03-01 MA MA32663A patent/MA31687B1/fr unknown
-
2012
- 2012-03-06 US US13/412,855 patent/US8420817B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2865330T3 (es) | Azabenzimidazoles y su uso como moduladores del receptor AMPA | |
| PE20091307A1 (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un grupo silanilo, su preparacion y su aplicacion en terapeutica | |
| PE20081689A1 (es) | Derivados de n-(heteroaril)-1-heteroaril-1h-indol-2-carboxamidas y su preparacion | |
| PE20050951A1 (es) | Compuestos mimeticos de glucocorticoides, metodos de preparacion y composiciones farmaceuticas | |
| PE20091403A1 (es) | Derivados de carboxamidas n-azabiciclicas y su preparacion | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| PE20091320A1 (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapautica | |
| PE20142216A1 (es) | Inhibidores de indazol de la ruta de senalizacion de wnt y usos terapeuticos de los mismos | |
| TW201011020A (en) | Substituted naphthyridines and their use as medicaments | |
| PE20070002A1 (es) | Compuestos derivados de heteroaril como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo i | |
| EP1987010A1 (fr) | Dérivés de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur préparation et leur application en thérapeutique | |
| AU2009224532A1 (en) | Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof | |
| PE20090370A1 (es) | Derivados de heterociclo fusionado como inhibidores de quinasa | |
| JP2009524676A5 (es) | ||
| NO20090979L (no) | (3-amino-1,2,3,4-tetrahydro-9H-karbazol-9-yl)-eddiksyrederivater | |
| PE20091350A1 (es) | Derivados de sulfonamidas sustituidas | |
| PE20071093A1 (es) | COMPUESTOS HETEROCICLICOS BICICLICOS COMO MODULADORES DEL RECEPTOR CRTh2 | |
| PE20090565A1 (es) | Derivados de n-heteroaril-carboxamidas triciclicas, su preparacion y su aplicacion en terapeutica | |
| PE20090960A1 (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas | |
| AU2020345962A1 (en) | USP30 inhibitors and uses thereof | |
| PE20091083A1 (es) | Moduladores tieno- y furo- pirimidina del receptor de histamina h4 | |
| PE20091436A1 (es) | Derivados de sulfonamidas sustituidas como moduladores b1r | |
| TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
| ATE487715T1 (de) | Triazolderivate als modulatoren von dopamin-d3- rezeptoren | |
| AU2003226724A8 (en) | Quinoline and aza-indole derivatives and their use as 5-ht6 ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |